Annual Operating Expenses
$551.57 M
+$41.28 M+8.09%
December 31, 2023
Summary
- As of February 7, 2025, NTLA annual total operating expenses is $551.57 million, with the most recent change of +$41.28 million (+8.09%) on December 31, 2023.
- During the last 3 years, NTLA annual operating expenses has risen by +$356.99 million (+183.47%).
- NTLA annual operating expenses is now at all-time high.
Performance
NTLA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$153.88 M
+$7.88 M+5.40%
September 30, 2024
Summary
- As of February 7, 2025, NTLA quarterly total operating expenses is $153.88 million, with the most recent change of +$7.88 million (+5.40%) on September 30, 2024.
- Over the past year, NTLA quarterly operating expenses has increased by +$10.78 million (+7.53%).
- NTLA quarterly operating expenses is now -1.04% below its all-time high of $155.50 million, reached on March 31, 2022.
Performance
NTLA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NTLA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.1% | +7.5% |
| 3 y3 years | +183.5% | +94.3% |
| 5 y5 years | +354.7% | +328.1% |
NTLA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.3% | -1.0% | +65.0% |
| 5 y | 5-year | at high | +269.0% | -1.0% | +278.0% |
| alltime | all time | at high | +2735.4% | -1.0% | +6102.4% |
Intellia Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $153.88 M(+5.4%) |
| Jun 2024 | - | $146.00 M(+2.1%) |
| Mar 2024 | - | $142.94 M(+3.6%) |
| Dec 2023 | $551.57 M(+8.1%) | $137.97 M(-3.6%) |
| Sep 2023 | - | $143.10 M(-1.9%) |
| Jun 2023 | - | $145.93 M(+17.2%) |
| Mar 2023 | - | $124.56 M(+0.7%) |
| Dec 2022 | $510.29 M(+69.6%) | $123.66 M(+4.1%) |
| Sep 2022 | - | $118.80 M(+5.8%) |
| Jun 2022 | - | $112.33 M(-27.8%) |
| Mar 2022 | - | $155.50 M(+66.7%) |
| Dec 2021 | $300.90 M(+54.6%) | $93.27 M(+17.8%) |
| Sep 2021 | - | $79.20 M(+4.8%) |
| Jun 2021 | - | $75.57 M(+42.9%) |
| Mar 2021 | - | $52.87 M(+7.9%) |
| Dec 2020 | $194.58 M(+30.2%) | $48.99 M(-2.6%) |
| Sep 2020 | - | $50.32 M(+2.1%) |
| Jun 2020 | - | $49.30 M(+7.3%) |
| Mar 2020 | - | $45.96 M(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $149.47 M(+23.2%) | $40.71 M(+13.3%) |
| Sep 2019 | - | $35.94 M(-6.8%) |
| Jun 2019 | - | $38.58 M(+12.7%) |
| Mar 2019 | - | $34.24 M(+19.6%) |
| Dec 2018 | $121.30 M(+26.8%) | $28.63 M(-9.1%) |
| Sep 2018 | - | $31.51 M(+0.8%) |
| Jun 2018 | - | $31.27 M(+4.6%) |
| Mar 2018 | - | $29.90 M(-4.7%) |
| Dec 2017 | $95.67 M(+96.7%) | $31.38 M(+35.3%) |
| Sep 2017 | - | $23.19 M(+5.7%) |
| Jun 2017 | - | $21.93 M(+14.5%) |
| Mar 2017 | - | $19.16 M(+16.5%) |
| Dec 2016 | $48.64 M(+150.0%) | $16.45 M(+30.9%) |
| Sep 2016 | - | $12.57 M(+12.7%) |
| Jun 2016 | - | $11.15 M(+31.6%) |
| Mar 2016 | - | $8.47 M(+17.9%) |
| Dec 2015 | $19.45 M | $7.18 M(+44.0%) |
| Sep 2015 | - | $4.99 M(+4.0%) |
| Jun 2015 | - | $4.80 M(+93.4%) |
| Mar 2015 | - | $2.48 M |
FAQ
- What is Intellia Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Intellia Therapeutics?
- What is Intellia Therapeutics annual operating expenses year-on-year change?
- What is Intellia Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly operating expenses year-on-year change?
What is Intellia Therapeutics annual total operating expenses?
The current annual operating expenses of NTLA is $551.57 M
What is the all time high annual operating expenses for Intellia Therapeutics?
Intellia Therapeutics all-time high annual total operating expenses is $551.57 M
What is Intellia Therapeutics annual operating expenses year-on-year change?
Over the past year, NTLA annual total operating expenses has changed by +$41.28 M (+8.09%)
What is Intellia Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of NTLA is $153.88 M
What is the all time high quarterly operating expenses for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly total operating expenses is $155.50 M
What is Intellia Therapeutics quarterly operating expenses year-on-year change?
Over the past year, NTLA quarterly total operating expenses has changed by +$10.78 M (+7.53%)